AI for drug development: Experts break down what’s possible — and what’s just hype
People like to throw around buzzwords like ‘AI’ and ‘big data,’ but in a STAT panel this week, experts broke through the hype to talk about what’s real.
If a group of chemists found 18 more potent versions of a drug out of a sea of 3,000 potential chemicals in the span of a few weeks, they might be hailed as superhumans.
That actually happened at Relay Therapeutics, said Dr. Donald Bergstrom, the company’s head of R&D. But the driving force behind it wasn’t human at all — it was artificial intelligence.
AI and machine learning have been hailed as a powerful new tool for drug discovery. But despite the hype, there is still a huge gap between the potential and the reality.
